Breaking News Instant updates and real-time market news.

KR

Kroger

$32.20

-0.9 (-2.72%)

, SVU

Supervalu

$4.72

-0.02 (-0.42%)

09:53
11/30/16
11/30
09:53
11/30/16
09:53

Kroger drop as Albertsons said near deal to bulk up

Shares of Kroger (KR) and other supermarket companies are in focus this morning following a report that Albertsons is in advanced discussions to buy Price Chopper for about $1B. WHAT'S NEW: Reuters reported, citing people familiar with the matter, that privately-held U.S. supermarket operator Albertsons is is "advanced" talks to acquire Price Chopper, another privately-held grocery store operator, for about $1B. Albertsons is the second-largest U.S. grocery chain after Kroger, the Reuters report notes. Albertsons is owned by private equity firm Cerberus Capital Management and operates more than 2,200 supermarkets. WHAT'S NOTABLE: In addition to consolidation in the U.S. grocery sector, U.S. supermarket chains are also facing steep competition against Wal-Mart (WMT) and other big box stores, as well as online retailers like Amazon (AMZN) and offerings from Walgreens (WBA) and Rite Aid (RAD). In 2015, Albertsons merged with Safeway. Earlier this year, Ahold merged with Delhaize, creating Ahold Delhaize (ADRNY) and combining Stop & Shop and Hannaford. Additionally, Walgreens is seeking FTC approval to buy Rite Aid for $17B, and Albertsons and Kroger have emerged as potential store divestiture suitors, according to a recent report from CTFN. PRICE ACTION: Kroger is down about 1.5% in early trading to $32.58, while SuperValu (SVU) is up 1% to $4.79. Whole Foods (WFM) and Sprouts Farmers Markets (SFM) are declining fractionally.

KR

Kroger

$32.20

-0.9 (-2.72%)

SVU

Supervalu

$4.72

-0.02 (-0.42%)

WMT

Wal-Mart

$70.66

-0.7056 (-0.99%)

AMZN

Amazon.com

$762.52

-4.25 (-0.55%)

WBA

Walgreens Boots Alliance

$85.53

0.18 (0.21%)

RAD

Rite Aid

$8.02

-0.03 (-0.37%)

ADRNY

Ahold Delhaize

$20.05

-0.13 (-0.64%)

WFM

Whole Foods

$30.61

-0.33 (-1.07%)

SFM

Sprouts Farmers Markets

$20.48

-0.67 (-3.17%)

  • 01

    Dec

  • 01

    Dec

  • 05

    Dec

  • 13

    Dec

KR Kroger
$32.20

-0.9 (-2.72%)

09/23/16
LEHM
09/23/16
INITIATION
Target $33
LEHM
Equal Weight
Kroger initiated with an Equal Weight at Barclays
Barclays analyst Karen Short started Kroger with an Equal Weight rating and $33 price target.
10/10/16
OPCO
10/10/16
NO CHANGE
OPCO
Wal-Mart 'starting to get its act together' in grocery, says Oppenheimer
After attending Wal-Mart's (WMT) analyst day meeting, Oppenheimer analyst Rupesh Parikh admitted he did not previously look favorably upon the company's strategy to expand into Neighborhood Market and smaller format stores, but he now sees signs that the company is "starting to get its act together in grocery." If Wal-Mart follows through with grocery price investments, it could hurt Kroger (KR), Smart & Final Stores (SFS) and Supervalu (SVU) and be an "indirect negative" for Sprouts Farmers Markets (SFM), Parikh tells investors. However, he also added that he remains confident in the ability of Kroger's management team to at least hold share.
10/07/16
SBSH
10/07/16
NO CHANGE
Target $39
SBSH
Buy
Citi says Whole Foods buyout would be uncharacteristic for Kroger
Citi analyst Alvin Concepcion weighs in on the speculation yesterday that Kroger (KR) could be interested in acquiring Whole Foods (WFM) for $40 per share. There are challenges that reduce the likelihood of a deal, and such a transaction could be uncharacteristic for Kroger, Concepcion tells investors in a research note. For one, the acquisition would be expensive, the analyst contends. And two, Kroger would have to lever up to 3.5 times net debt/EBITDA, he adds. The analyst keeps a Buy rating on Kroger with a $39 price target. Whole Foods yesterday closed up 5% to $29.33 amid the takeout rumor.
10/07/16
PIVT
10/07/16
NO CHANGE
PIVT
Whole Foods FY17 earnings risk not fully appreciated, says Pivotal Research
Pivotal Research said recent chatter involving Kroger (KR) and Whole Foods (WFM) follows a steady stream of bogus takeover rumors that seem to surface with little or no reasonable basis. The firm's analyst said this appears to be another head fake that distracts from core challenges facing Whole Foods ahead of 4Q16 results in early November and potential disappointing FY17 guidance. Pivotal said although Whole Foods multiple is not demanding, the extent of a FY17 earnings risk is not fully appreciated by the Street.
SVU Supervalu
$4.72

-0.02 (-0.42%)

01/14/16
TLSY
01/14/16
DOWNGRADE
TLSY
Market Perform
Supervalu downgraded to Market Perform from Outperform at Telsey Advisory
01/14/16
01/14/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Alcoa (AA) downgraded on earnings estimates outlook at Argus... Atmel (ATML) downgraded to Market Perform from Outperform at Raymond James... Belmond Ltd (BEL) downgraded to Sell from Buy at MKM Partners... BorgWarner (BWA) downgraded to Underperform from Buy at CLSA... Choice Hotels (CHH) downgraded to Sell from Neutral at MKM Partners... Discover (DFS) downgraded to Neutral from Overweight at JPMorgan... Extended Stay America (STAY) downgraded to Neutral from Buy at MKM Partners... F5 Networks (FFIV) downgraded to Underweight from Equal Weight at Barclays... GoPro (GPRO) downgraded to Equal Weight from Overweight at Barclays... Hilton (HLT) downgraded to Sell from Buy at MKM Partners... Hudbay Minerals (HBM) downgraded to Underweight from Overweight at Barclays... Hyatt (H) downgraded to Sell from Neutral at MKM Partners... Ivanhoe Mines (IVPAF) downgraded to Market Perform from Outperform at BMO Capital... LafargeHolcim (HCMLY) downgraded to Neutral from Overweight at JPMorgan... Lundin Mining (LUNMF) downgraded to Equal Weight from Overweight at Barclays... Marriott (MAR) downgraded to Neutral from Buy at MKM Partners... Morgans Hotel (MHGC) downgraded to Sell from Buy at MKM Partners... NVIDIA (NVDA) downgraded to Underweight from Equal Weight at Barclays... OMV AG (OMVKY) downgraded to Sell from Neutral at UBS... PacWest Bancorp (PACW) downgraded to Market Perform from Outperform at BMO Capital... Supervalu (SVU) downgraded to Hold from Buy at Deutsche Bank... TE Connectivity (TEL) downgraded to Neutral from Buy at Longbow... Tandem Diabetes (TNDM) downgraded to Neutral from Buy at BofA/Merrill... Tarena (TEDU) downgraded to Neutral from Outperform at Credit Suisse... Teck Resources (TCK) downgraded to Underweight from Equal Weight at Barclays... TransGlobe (TGA) downgraded to Underperformer from Sector Performer at CIBC... Ubiquiti (UBNT) downgraded to Market Perform from Outperform at Bernstein... Ventas (VTR) downgraded to Market Perform from Outperform at BMO Capital... Welltower (HCN) downgraded to Market Perform from Outperform at BMO Capital... Yamana Gold (AUY) downgraded to Equal Weight from Overweight at Barclays... Yelp (YELP) downgraded to Sell from Neutral at B. Riley.
07/06/16
DBAB
07/06/16
NO CHANGE
Target $6
DBAB
Hold
Deutsche calls Marsh deal a 'nice win' for Supervalu
Deutsche Bank analyst Shane Higgins views the long-term supply agreement with Marsh Supermarkets as a "nice win" for Supervalu. The news is timely with Supervalu preparing for the separation of Save-A-Lot, Higgins tells investors in a research note. The analyst keeps a Hold rating on the shares, however, citing the "headwinds still facing the business."
WMT Wal-Mart
$70.66

-0.7056 (-0.99%)

10/27/16
JPMS
10/27/16
DOWNGRADE
Target $28
JPMS
Neutral
JPMorgan downgrades Vitamin Shoppe on 2017 earnings risk
JPMorgan analyst Christopher Horvers earlier today downgraded Vitamin Shoppe (VSI) to Neutral from Overweight and lowered his price target for the shares to $28 from $33. The analyst sees downside risk to 2017 earnings as the competitive environment worsens. GNC Holdings (GNC) under new management is testing major pricing and loyalty card changes while Vitamin Shoppe's comparable prices are higher versus Amazon (AMZN), Horvers tells investors in a research note. He sees Vitamin Shoppe "squeezed between" its three larger competitors, GNC, Wal-Mart (WMT) and Amazon. The stock is trading down $2.05 to $25.30 following GNC's Q3 results. GNC is trading down 20% to $16.04.
11/23/16
UBSW
11/23/16
NO CHANGE
Target $100
UBSW
Buy
Dollar Tree price target raised to $100 from $90 at UBS
UBS analyst Michael Lasser raised his price target on Dollar Tree (DLTR) to $100 from $90 following Q3 results. The analyst said the company's results eased a number of fears and demonstrated it could hold its own against competitors such as Wal-Mart (WMT). Dollar Tree exhibited comp growth, and its merger with Family dollar is providing synergies within its guidance, said Lasser, who reiterated his Buy rating on the shares.
11/17/16
BARD
11/17/16
NO CHANGE
Target $80
BARD
Outperform
Wal-Mart strategy remains on track, says Baird
Baird analyst Peter Benedict notes that this was a 'noisy' quarter for Wal-Mart, but underlying EPS effectively in line with expectations. While acknowledging that U.S. traffic gains slowed against a tougher compare and Q4 EPS guidance was viewed as a disappointment, the analyst believes Wal-Mart's strategy remains on track and 2017 EPS estimates appear largely de-risked. He reiterates an Outperform rating and $80 price target on the shares, given the company's defensive appeal within a still choppy consumer/retail backdrop.
11/11/16
BARD
11/11/16
NO CHANGE
Target $80
BARD
Outperform
Wal-Mart 2017 earnings somewhat de-risked, says Baird
Baird analyst Peter Benedict expects Wal-Mart's Q3 results to be generally in-line as investments in associates, processes, and prices are working together to drive improved customer satisfaction and sales. The company's 2017 estimates appear to be de-risked as management reset margin and earnings expectations at last month's investor meeting, said Benedict, who reiterated his Outperform rating and $80 price target on Wal-Mart shares.
AMZN Amazon.com
$762.52

-4.25 (-0.55%)

11/28/16
CLVD
11/28/16
NO CHANGE
CLVD
Amazon expanding lab distribution capabilities, says Cleveland Research
Cleveland Research said Amazon.com (AMZN) has been expanding its capabilities towards larger customers and can now offer purchase orders adn volume based specific pricing, causing larger customers to reevaluate Amazon as a possible distributor for both Lab and non-Lab purchases. The firm believes Stanford University has recently decided not to renew its Thermo Labs (TMO) primary lab distribution contract and the scool will start using both Amazon and Thermo for its lab product needs.
11/28/16
SBSH
11/28/16
NO CHANGE
Target $960
SBSH
Buy
Citi trims Amazon price target on lower AWS estimates
To reflect the reduced storage prices announced last week by Amazon Web Services, Citi analyst Mark May cut his AWS revenue and consolidated segment operating income for 2017 by 3% and 9%, respectively. The analyst, however, does not view the price reductions as an indication of competitive pressures or a threat to long-term margin outlook for AWS. May lowered his price target for Amazon.com shares to $960 from $965 and keeps a Buy rating on name. His new price target reflects 23% upside from current levels.
11/28/16
OPCO
11/28/16
NO CHANGE
OPCO
Initial eCommerce data points show stable trends, says Oppenheimer
Oppenheimer analyst Jason Helfstein says initial eCommerce data points show stable trends ahead of Cyber-Monday, after Adobe (ADBE) and ComScore (SCOR) released online retail sales data for Thanksgiving and Black Friday. The analyst notes that Adobe recorded $5.3B in online spending during the two-day period, over 18% year over year, same as last year, but points out that the company does not measure Amazon (AMZN) sales, as data reflects sales from "Adobe Marketing Cloud" clients. On the other hand, Helfstein says comScore data showed "significant" acceleration, with spending over 18% year over year to $3.3B during the two-day period.
11/29/16
LBOW
11/29/16
NO CHANGE
LBOW
Fitbit 'dominated' best seller lists on Black Friday, says Longbow
Longbow analyst Joe Wittine says that Fitbit (FIT) "dominated" best-seller lists on Black Friday, propelled by steep discounts at Amazon (AMZN) and Target (TGT). However, the analyst adds that Internet searches for Fitbit on Black Friday dropped 11% versus Black Friday 2015. He keeps a Neutral rating on the stock.
WBA Walgreens Boots Alliance
$85.53

0.18 (0.21%)

11/08/16
JEFF
11/08/16
NO CHANGE
Target $95
JEFF
Buy
Walgreens could benefit from drug pricing pressure, says Jefferies
Jefferies analyst Brian Tanquilut says concerns about the impact of decelerating branded drug price inflation on the pharma supply chain do not necessarily apply to Walgreens Boots Alliance. The company could actually benefit, Tanquilut tells investors in a research note. 85% of the drugs dispensed by Walgreens are generic medications and any semblance of price deflation in that category of drugs should translate into margin expansion opportunities for the company, the analyst contends. He remains bullish on shares of Walgreens with a Buy rating and $95 price target.
11/09/16
DBAB
11/09/16
NO CHANGE
Target $88
DBAB
Buy
Deutsche still expects Walgreens, Rite Aid deal to close
After speaking to private equity executives, Deutsche Bank analyst George Hill continues to expect Walgreens Boots Alliance's acquisition of Rite Aid (RAD) to be completed. The analyst says the conversations support his belief that most of the divested stores will go to strategic buyers, which he thinks is the FTC preference. Hill has a Buy rating on Walgreens with an $88 price target.
11/15/16
LEER
11/15/16
NO CHANGE
Target $85
LEER
Outperform
CVS Health price target lowered to $85 from $105 at Leerink
Leerink analyst David Larsen lowered his price target for CVS Health (CVS) to $85 from $105 as he is incrementally more cautious on the company. Conversely, the analyst is incrementally more positive on Walgreens Boots Alliance (WBA) and believes its deal with Rite Aid (RAD) deal is more likely to go through with Trump as President. Nonetheless, Larsen believes that 2017 is largely a re-set year for CVS Health, and expects the business to return to more robust growth in 2018 and beyond. He reiterates an Outperform rating on CVS Health's shares.
11/08/16
LEER
11/08/16
NO CHANGE
Target $90
LEER
Outperform
Walgreens Boots Alliance price target lowered to $90 from $95 at Leerink
Leerink analyst David Larsen lowered his price target for Walgreens Boots Alliance (WBA) to $90 from $95, noting that he is negatively surprised that Rite Aid (RAD) is expected to add just 5c-12c to 2017 EPS, and also somewhat concerned that 2017 is expected to be a back-half loaded year. Furthermore, the analyst is slightly more cautious on Rite Aid deal's odds, but sees about 65% chance of it closing. Larsen reiterates an Outperform rating on Walgreens Boots Alliance's shares.
RAD Rite Aid
$8.02

-0.03 (-0.37%)

10/20/16
DBAB
10/20/16
NO CHANGE
Target $88
DBAB
Buy
Deutsche still sees positive outcome for Walgreens, Rite Aid deal
Deutsche Bank analyst George Hill continues to expect Walgreens Boots Alliance's (WBA) acquisition of Rite Aid (RAD) to have a positive outcome. The analyst notes, however, that he'd be less positive on Walgreens with no deal, saying the promises the company made to its new pharmacy benefit managers partners around the ability to expand its network would be much harder to execute if the deal does not close. Hill keeps a Buy rating on Walgreens but lowered his price target for the shares to $88 from 94.
ADRNY Ahold Delhaize
$20.05

-0.13 (-0.64%)

11/18/16
DBAB
11/18/16
DOWNGRADE
DBAB
Hold
Ahold Delhaize downgraded to Hold from Buy at Deutsche Bank
Price target lowered to EUR 22.50 from EUR 24.
09/07/16
DBAB
09/07/16
INITIATION
DBAB
Buy
Ahold Delhaize reinstated with a Buy at Deutsche Bank
Deutsche Bank analyst Niamh McSherry reinstated Ahold Delhaize with a Buy rating and EUR 25 price target.
10/04/16
EXAN
10/04/16
UPGRADE
EXAN
Outperform
Ahold Delhaize upgraded to Outperform from Neutral at Exane BNP Paribas
Exane BNP Paribas analyst Andrew Gwynn upgraded Ahold Delhaize to Outperform with a price target of EUR 23.50.
WFM Whole Foods
$30.61

-0.33 (-1.07%)

11/03/16
JEFF
11/03/16
NO CHANGE
JEFF
Too early to say if Whole Foods comp improvement sustainable, says Jefferies
After Whole Foods reported higher than expected Q4 EPS, Jefferies analyst Christopher Mandeville says that the company's basket andtraffic trends have shown improvement so far this quarter. However, the analyst says that the outlook for the company's comp sales is still uncertain, while its return on invested capital is still set to decline again in 2017. He thinks that the company's stock may not yet be out of the woods, and he keeps a Hold rating on the shares.
11/04/16
BOFA
11/04/16
DOWNGRADE
BOFA
Underperform
Whole Foods downgraded to Underperform from Neutral at BofA/Merrill
11/04/16
11/04/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Whole Foods downgraded to Underperform from Neutral at BofA/Merrill with analyst Robert Ohmes saying he sees increased risks to Whole Foods' comp and margin outlook from the difficult operating environment. 2. Michaels (MIK) downgraded to Neutral from Buy at BofA/Merrill with analyst Denise Chai saying competitors are getting more aggressive with increased new store growth and promotions and expects Michaels comps to remain muted and margins to be "flattish." 3. MDC Partners (MDCA) downgraded to Market Perform from Outperform at BMO Capital, to Market Perform from Outperform at Wells Fargo, and to Neutral from Outperform at Wedbush. 4. Fluor (FLR) downgraded to Neutral from Buy at DA Davidson, to Neutral from Outperform at Macquarie, to Hold from Accumulate at Johnson Rice, and to Market Perform from Outperform at William Blair. 5. Cornerstone OnDemand (CSOD) downgraded to Neutral from Outperform at Credit Suisse, to Underweight from Neutral at JPMorgan, to Neutral from Buy at UBS, and to Buy from Strong Buy at Needham. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/04/16
11/04/16
DOWNGRADE
Target $25

Underperform
Whole Foods downgraded to Underperform on weaking comps at BofA/Merrill
As previously reported, BofA/Merrill downgraded Whole Foods to Underperform from Neutral and lowered its price target to $25 from $34. Analyst Robert Ohmes sees increased risks to Whole Foods' comp and margin outlook from the difficult operating environment. The analyst expects lower priced competitors and increased promotions to keep comps negative into FY18 and for EBIT margins to trend lower due to expanded price investments, promotions, and marketing expenses.
SFM Sprouts Farmers Markets
$20.48

-0.67 (-3.17%)

11/04/16
RHCO
11/04/16
NO CHANGE
RHCO
Sprouts Farmers Markets still has positive catalysts, says SunTrust
After Sprouts reported lower than expected Q3 EPS but its SSS exceeded its plan and the stock fell 10%, SunTrust analyst David Magee says that the company is being hurt by "seemingly endless deflation." However, the analyst continues to believe that its pricing trends can normalize in 1H17, while the company's new stores are "performing exceptionally well." He says that the company's store level ROIC is "very high," and he reiterates a Buy rating.
09/30/16
JEFF
09/30/16
UPGRADE
Target $24
JEFF
Buy
Sprouts Farmers Markets upgraded to Buy from Hold at Jefferies
Jefferies analyst Christopher Mandeville upgraded Sprouts Farmers Markets to Buy saying the risk/reward is now favorable following the recent pullback in the shares. The analyst sees limited downside and an "attractive buying opportunity for a name with 12-14% EBITDA growth." He lowered his price target for the shares to $24 from $25.
09/30/16
09/30/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded on potential NXP Semiconductors acquisition at Mizuho with the firm's analyst saying he believes a Qualcomm acquisition of NXP Semiconductors (NXPI) makes significant strategic and financial sense. 2. Skechers (SKX) upgraded to Positive from Neutral at Susquehanna. 3. Sprouts Farmers Markets (SFM) upgraded to Buy from Hold at Jefferies with analyst Christopher Mandeville saying the risk/reward is now favorable following the recent pullback in the shares. 4. Phillips 66 (PSX) upgraded to Neutral from Sell at Goldman with analyst Neil Mehta citing higher multiple assumptions for midstream and chemicals segments, reduced capex spending and higher free cash flow estimates, and more achievable consensus expectations. 5. NetApp (NTAP) upgraded to Buy from Sell at Summit Redstone with analyst Srini Nandury citing optimism that the company can grow its product revenue from current levels driven by AFA sales and increasing adoption of clustered ONTAP. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

RHHBY

Roche

$27.67

0.47 (1.73%)

20:25
12/05/16
12/05
20:25
12/05/16
20:25
Conference/Events
Roche to hold an analyst meeting »

Analyst Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AZO

AutoZone

$776.42

-7.32 (-0.93%)

, HDS

HD Supply

$39.75

0.67 (1.71%)

20:25
12/05/16
12/05
20:25
12/05/16
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

AZO

AutoZone

$776.42

-7.32 (-0.93%)

HDS

HD Supply

$39.75

0.67 (1.71%)

MIK

Michaels

$24.31

0.34 (1.42%)

TOL

Toll Brothers

$30.47

1.15 (3.92%)

BOBE

Bob Evans

$46.77

1.05 (2.30%)

CONN

Conn's

$11.20

0.4 (3.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 14

    Dec

  • 09

    Jan

GDDY

GoDaddy

$34.74

1.45 (4.36%)

20:14
12/05/16
12/05
20:14
12/05/16
20:14
Hot Stocks
GoDaddy acquires WP Curve »

WP Curve announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.99

0.9 (1.21%)

20:10
12/05/16
12/05
20:10
12/05/16
20:10
Earnings
Belden sees FY17 adjusted EPS $5.00-$5.25, consensus $5.23 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SGMO

Sangamo

19:39
12/05/16
12/05
19:39
12/05/16
19:39
Hot Stocks
Sangamo reports preclinical, manufacturing data on SB-525, says IND on track »

Sangamo BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SGEN

Seattle Genetics

$66.26

-0.44 (-0.66%)

, BMY

Bristol-Myers

$55.55

-0.41 (-0.73%)

19:38
12/05/16
12/05
19:38
12/05/16
19:38
Hot Stocks
Seattle Genetics, Bristol-Myers: Data supports ADCETRIS, Opdivo combo »

Seattle Genetics (SGEN)…

SGEN

Seattle Genetics

$66.26

-0.44 (-0.66%)

BMY

Bristol-Myers

$55.55

-0.41 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

LGIH

LGI Homes

$32.34

0.45 (1.41%)

19:36
12/05/16
12/05
19:36
12/05/16
19:36
Hot Stocks
LGI Homes reports November home closings up 28.9% y/y »

LGI Homes announced 321…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$116.56

-1.07 (-0.91%)

19:36
12/05/16
12/05
19:36
12/05/16
19:36
Hot Stocks
Celgene reports analysis of three CC-486 studies »

Celgene announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

BLUE

bluebird bio

$72.15

2.4 (3.44%)

19:35
12/05/16
12/05
19:35
12/05/16
19:35
Hot Stocks
bluebird bio provides updates on HSC gene therapy programs »

bluebird bio provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGIO

Agios Pharmaceuticals

$49.88

-7.09 (-12.45%)

19:33
12/05/16
12/05
19:33
12/05/16
19:33
Hot Stocks
Agios 'encouraged' by durable clinical activity of AG-120 »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$60.25

-0.88 (-1.44%)

19:31
12/05/16
12/05
19:31
12/05/16
19:31
Hot Stocks
Merck: KEYNOTE-087 trial data shows oORR of 69%, CRR of 22.4% »

Merck announced updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 08

    Mar

TWX

Time Warner

$93.34

-0.46 (-0.49%)

, T

AT&T

$38.63

0.02 (0.05%)

19:29
12/05/16
12/05
19:29
12/05/16
19:29
Periodicals
Time Warner 'struggling to expand' HBO Now, NY Post says »

Time Warner (TWX) is…

TWX

Time Warner

$93.34

-0.46 (-0.49%)

T

AT&T

$38.63

0.02 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

BP

BP

, REPYY

Repsol

$13.88

0.25 (1.83%)

19:18
12/05/16
12/05
19:18
12/05/16
19:18
Periodicals
BP acquires Repsol stake in Indonesia LNG plant, Reuters says »

BP (BP) has purchased…

BP

BP

REPYY

Repsol

$13.88

0.25 (1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOSUF

Fosun

19:12
12/05/16
12/05
19:12
12/05/16
19:12
Hot Stocks
Liberty Mutual to acquire Fosun subsidiary Ironshore for roughly $3B »

Liberty Mutual Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$49.75

-0.06 (-0.12%)

, YHOO

Yahoo

$40.20

0.13 (0.32%)

18:54
12/05/16
12/05
18:54
12/05/16
18:54
Periodicals
AOL CEO 'cautiously optimistic' Verizon-Yahoo deal will go through, WSJ says »

AOL CEO Tim Armstrong…

VZ

Verizon

$49.75

-0.06 (-0.12%)

YHOO

Yahoo

$40.20

0.13 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 24

    Jan

TUWOY

Tullow Oil

$2.06

0.109 (5.58%)

18:46
12/05/16
12/05
18:46
12/05/16
18:46
Downgrade
Tullow Oil rating change  »

Tullow Oil downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBNK

Guaranty Bancorp

$22.15

0.75 (3.50%)

18:43
12/05/16
12/05
18:43
12/05/16
18:43
Hot Stocks
Breaking Hot Stocks news story on Guaranty Bancorp »

Castle Creek raises stake…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATKR

Atkore

$20.48

-0.18 (-0.87%)

18:41
12/05/16
12/05
18:41
12/05/16
18:41
Syndicate
Atkore files to sell 8M shares of common stock for holders »

The offering is being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$107.42

-0.8 (-0.74%)

18:38
12/05/16
12/05
18:38
12/05/16
18:38
Hot Stocks
United Technologies CEO: No quid pro quo on taxes in Carrier deal with Trump »

Says Carrier agreement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPDN

Professional Diversity Network

$9.75

-0.01 (-0.10%)

18:37
12/05/16
12/05
18:37
12/05/16
18:37
Hot Stocks
Breaking Hot Stocks news story on Professional Diversity Network »

North Star cuts passive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHXM

DHX Media

$5.05

-0.36 (-6.65%)

18:33
12/05/16
12/05
18:33
12/05/16
18:33
Hot Stocks
Breaking Hot Stocks news story on DHX Media »

Luxor Capital cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPHS

Trinity Place

$10.02

0.08 (0.80%)

18:24
12/05/16
12/05
18:24
12/05/16
18:24
Hot Stocks
Trinity Place Holdings, Pacolet Milliken acquire Brooklyn building for $68.8M »

Trinity Place Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SU

Suncor

$32.46

0.23 (0.71%)

18:07
12/05/16
12/05
18:07
12/05/16
18:07
Hot Stocks
Suncor Energy resolves C$1.3B tax dispute with Canada Revenue Agency »

Suncor Energy reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRN

Acceleron

$34.90

-1.39 (-3.83%)

, CELG

Celgene

$116.56

-1.07 (-0.91%)

18:07
12/05/16
12/05
18:07
12/05/16
18:07
Hot Stocks
Acceleron, Celgene report Phase 2 data on luspatercept in beta-thalassemia »

Acceleron Pharma (XLRN)…

XLRN

Acceleron

$34.90

-1.39 (-3.83%)

CELG

Celgene

$116.56

-1.07 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

SNSS

Sunesis

$4.02

0.12 (3.08%)

17:54
12/05/16
12/05
17:54
12/05/16
17:54
Hot Stocks
Sunesis says new VALOR trial data show 'compelling durable survival outcomes' »

Sunesis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.